The 2011 Top Ten World's Leading Life Science Intermediates Companies

Date: October 22, 2010
Pages: 600
Price:
US$ 12,500.00 US$ 10,625.00
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: TF0089AE1AFEN
Leaflet:

Download PDF Leaflet

The 2011 Top Ten World's Leading Life Science Intermediates Companies
Global PDF: US$ 27,500.00

A strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability. Timely and factual competitive intelligence is vital to the success of all business functions, particularly Planning, Marketing, R&D, and Manufacturing.

In a highly dynamic and fragmented life science intermediates market, besieged by intense competition and rapid pace of technological innovations, the ability to anticipate new competitive product introductions and marketing strategies is particularly important... and can spell the difference between success and failure.

This unique multi-client study was prepared by Venture Planning Group in order to provide industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs. The study’s major objectives include:
  • To establish a comprehensive, factual and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading life science intermediates companies.
  • To help current suppliers realistically assess their financial, technological and marketing capabilities vis-a-vis leading competitors.
  • To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
  • To complement organizations’ internal competitor information gathering efforts with strategic analysis, data interpretation and insight.
The Top 10 report is based on a combination of primary and secondary information sources, including Venture Planning Group’s proprietary database, developed during the firm’s continuous monitoring of the industry, as well as over 100 syndicated multiclient studies and numerous proprietary single-client assignments. This database contains information on major life science intermediates companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the Top 10 companies’ product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 600 pages and 84 tables
SECTION I. EXECUTIVE SUMMARY

A 3-5 page synopsis of main sections.

SECTION II. BUSINESS ORGANIZATION

History of the life science intermediates business evolution, important to the understanding of the corporate culture, management mentality and strategies.
Recent acquisitions, divestitures and significant organizational changes.
Current organizational structure.

SECTION III. SENIOR MANAGEMENT

Background of key executives.

SECTION IV. FACILITIES AND EMPLOYEES

Major administrative, manufacturing and R&D facilities in the U.S. and abroad.
New plants under construction.
U.S. and international work force size and distribution.

SECTION V.TECHNOLOGICAL KNOW-HOW

Internally developed and acquired technologies, and related capabilities.
Proprietary technologies and patent litigations.

SECTION VI. PRODUCT PORTFOLIO

Extensive review of major product lines.
New product introductions and line extensions.

SECTION VII. MARKETING TACTICS

Major promotional strategies.
Distribution approaches.
Product service and support.

SECTION VIII. FINANCIAL ANALYSIS

Sales and operating profit by division, product line, geographic region and country.
Five-year sales and profit performance.

SECTION IX. R&D EXPENDITURES AND MAJOR PROGRAMS

Estimated R&D budget.
Research facilities and staff.
New technologies, products and applications in development.

SECTION X. COLLABORATIVE ARRANGEMENTS

Major joint venture, distribution, OEM and licensing partners, both industrial and academic.
Terms of collaborative agreements and specific products involved.

SECTION XI. STRATEGIC DIRECTION

Specific business, new product development and marketing strategies.
Strengths and weaknesses.
Anticipated acquisitions, joint ventures and divestitures.

LIST OF TABLES

TABLE BF-1:BASF SALES AND OPERATING PROFIT GROWTH
TABLE BF-2:BASF SALES BY BUSINESS SEGMENT
TABLE BF-3:BASF SALES GROWTH BY BUSINESS SEGMENT
TABLE BF-4:BASF OPERATING PROFIT BY BUSINESS SEGMENT
TABLE BF-5:BASF PLASTICS SALES BY DIVISION
TABLE BF-6:BASF PERFORMANCE PRODUCTS SALES BY DIVISION
TABLE BF-7:BASF CHEMICAL SALES BY DIVISION
TABLE BF-8:BASF AGRICULTURAL PRODUCTS AND NUTRITION SALES BY DIVISION
TABLE BF-9:BASF SALES BY GEOGRAPHIC REGION
TABLE BR-1:BAYER SALES BY BUSINESS SEGMENT
TABLE BR-2:BAYER SALES GROWTH BY BUSINESS SEGMENT
TABLE BR-3:BAYER SALES BY GEOGRAPHIC REGION
TABLE BR-4:BAYER SALES GROWTH BY GEOGRAPHIC REGION
TABLE BR-5:LANXESS SALES AND OPERATING PROFIT GROWTH
TABLE BR-6:LANXESS SALES BY PRODUCT LINE
TABLE BR-7:LANXESS SALES GROWTH BY PRODUCT LINE
TABLE CX-1:CAMBREX SALES AND OPERATING PROFIT GROWTH
TABLE CX-2:CAMBREX SALES BY BUSINESS SEGMENT
TABLE CX-3:CAMBREX SALES GROWTH BY BUSINESS SEGMENT
TABLE CX-4:CAMBREX OPERATING PROFIT AND MARGINS BY BUSINESS SEGMENT
TABLE CX-5:CAMBREX OPERATING PROFIT GROWTH BY BUSINESS SEGMENT
TABLE CX-6:CAMBREX SALES BY PRODUCT GROUP
TABLE CX-7:CAMBREX SALES GROWTH BY PRODUCT GROUP
TABLE CX-8:CAMBREX SALES BY GEOGRAPHIC REGION
TABLE CX-9:CAMBREX SALES GROWTH BY GEOGRAPHIC REGION
TABLE CL-1:CLARIANT SALES BY DIVISION
TABLE CL-2:CLARIANT SALES GROWTH BY DIVISION
TABLE CL-3:CLARIANT PROFIT BY DIVISION
TABLE CL-4:CLARIANT PROFIT GROWTH BY DIVISION
TABLE CL-5:CLARIANT SALES BY GEOGRAPHIC REGION
TABLE DE-1:EVONIK SALES AND OPERATING PROFIT GROWTH
TABLE DE-2:EVONIK SALES BY DIVISION
TABLE DE-3:EVONIK SALES GROWTH BY DIVISION
TABLE DE-4:EVONIK FINE AND INDUSTRIAL CHEMICAL SALES BY BUSINESS UNIT
TABLE DE-5:EVONIK COATINGS AND ADVANCED FILLERS SALES BY BUSINESS UNIT
TABLE DE-6:EVONIK PERFORMANCE MATERIALS SALES BY BUSINESS UNIT
TABLE DE-7:EVONIK CONSTRUCTION CHEMICALS SALES BY BUSINESS UNIT
TABLE DE-8:EVONIK SPECIALTY POLYMERS SALES BY BUSINESS UNIT
TABLE DE-9:EVONIK SALES BY GEOGRAPHIC REGION AND COUNTRY
TABLE DO-1:DOW CHEMICAL SALES AND OPERATING PROFIT GROWTH
TABLE DO-2:DOW CHEMICAL SALES BY OPERATING SEGMENT
TABLE DO-3:DOW CHEMICAL SALES GROWTH BY OPERATING SEGMENT
TABLE DO-4:DOW CHEMICAL SALES BY GEOGRAPHIC REGION
TABLE DO-5:DOW CHEMICAL SALES GROWTH BY GEOGRAPHIC REGION
TABLE DM-1:DSM SALES AND OPERATING PROFIT GROWTH
TABLE DM-2: DSM SALES BY DIVISION
TABLE DM-3: DSM SALES GROWTH BY DIVISION
TABLE DM-4:DSM OPERATING PROFIT BY DIVISION
TABLE DM-5:DSM OPERATING PROFIT GROWTH BY DIVISION
TABLE DM-6:DSM LIFE SCIENCE PRODUCTS SALES BY BUSINESS GROUP
TABLE DM-7:DSM LIFE SCIENCE PRODUCTS SALES GROWTH BY BUSINESS GROUP
TABLE DM-8:DSM PERFORMANCE MATERIALS SALES BY BUSINESS GROUP
TABLE DM-9:DSM PERFORMANCE MATERIALS SALES GROWTH BY BUSINESS GROUP
TABLE DM-10: DSM INDUSTRIAL CHEMICALS SALES BY BUSINESS GROUP
TABLE DM-11: DSM INDUSTRIAL CHEMICALS SALES GROWTH BY BUSINESS GROUP
TABLE DS-1:GROUPE NOVASEP PROFORMA SALES BY CUSTOMER GROUP
TABLE LO-1:LONZA SALES AND OPERATING PROFIT GROWTH
TABLE LO-2:LONZA SALES BY DIVISION
TABLE LO-3:LONZA SALES GROWTH BY DIVISION
TABLE LO-4:LONZA OPERATING PROFIT BY DIVISION
TABLE LO-5:LONZA OPERATING PROFIT GROWTH BY DIVISION
TABLE LO-6:LONZA EXCLUSIVE SYNTHESIS & BIOPHARMACEUTICAL DIVISION SALES BY MOLECULAR SIZE
TABLE LO-7:LONZA EXCLUSIVE SYNTHESIS & BIOPHARMACEUTICAL DIVISION SALES GROWTH BY MOLECULAR SIZE
TABLE LO-8:LONZA SALES BY GEOGRAPHIC REGION
TABLE LO-9:LONZA SALES GROWTH BY GEOGRAPHIC REGION
TABLE LO-10:LONZA EXCLUSIVE SYNTHESIS & PHARMACEUTICALS SALES BY GEOGRAPHIC REGION
TABLE LO-11:LONZA EXCLUSIVE SYNTHESIS & PHARMACEUTICALS SALES GROWTH BY GEOGRAPHIC REGION
TABLE LO-12:LONZA ORGANIC FINE & PERFORMANCE CHEMICALS SALES BY GEOGRAPHIC REGION
TABLE LO-13:LONZA ORGANIC FINE & PERFORMANCE CHEMICALS SALES GROWTH BY GEOGRAPHIC REGION
TABLE LO-14:LONZA POLYMER INTERMEDIATES SALES BY GEOGRAPHIC REGION
TABLE LO-15:LONZA POLYMER INTERMEDIATES SALES GROWTH BY GEOGRAPHIC REGION
TABLE RH-1:RHODIA SALES AND OPERATING PROFIT GROWTH
TABLE RH-2:RHODIA SALES BY ENTERPRISE
TABLE RH-3:RHODIA SALES GROWTH BY ENTERPRISE
TABLE RH-4:RHODIA OPERATING PROFIT AND MARGINS BY ENTERPRISE
TABLE RH-5:RHODIA OPERATING PROFIT GROWTH BY ENTERPRISE
TABLE RH-6:RHODIA SALES BY GEOGRAPHIC REGION AND COUNTRY
TABLE RH-7:RHODIA SALES GROWTH BY GEOGRAPHIC REGION AND COUNTRY
Skip to top


Ask Your Question

The 2011 Top Ten World's Leading Life Science Intermediates Companies
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: